Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours.
Neuroendocrine tumours (NETs) constitute a heterogeneous group of tumours that are able to express cell membrane neuroamine uptake mechanisms and/or specific receptors, such as somatostatin receptors, which can be of great value in the localization and treatment of these tumours. Scintigraphy with (...
Main Authors: | Kaltsas, G, Rockall, A, Papadogias, D, Reznek, R, Grossman, AB |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2004
|
Similar Items
-
Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues.
by: Kaltsas, G, et al.
Published: (2005) -
Targeted radionuclide therapy for neuroendocrine tumours: principles and application.
by: Druce, MR, et al.
Published: (2010) -
RADIONUCLIDE IMAGING AND THERAPY OF NEUROENDOCRINE TUMOURS
by: Shaunak Navalkissoor, et al.
Published: (2015-11-01) -
The clinical presentation (symptoms and signs) of sporadic and familial chromaffin cell tumours (phaeochromocytomas and paragangliomas).
by: Kaltsas, G, et al.
Published: (2004) -
Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
by: Kaltsas, G, et al.
Published: (2001)